NeoGenomics Laboratories
NeoGenomics is a leader in precision oncology testing, providing comprehensive cancer diagnostics and empowering healthcare professionals to enhance patient care.
Company facts
- Founded
- 2001
- Headquarters
- United States
- CEO
- Chris Smith
About
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world. Established in 2001, NeoGenomics has made significant contributions to the field of precision oncology through its commitment to quality diagnostics and patient care. Headquartered in Fort Myers, Florida, the company operates several CAP-accredited and CLIA-certified laboratories across the United States, ensuring compliance and high standards in diagnostic testing. With over 18 years of experience, NeoGenomics has developed a range of services that cater to oncologists, pathologists, and pharmaceutical companies. The company's extensive testing menu includes traditional diagnostic methods as well as cutting-edge genomic profiling techniques, which are essential for understanding the complexities of cancer. NeoGenomics' mission is to save lives by providing accurate and timely cancer diagnostics, facilitating personalized treatment plans for patients. The organization is dedicated to advancing cancer care through innovative technologies and strategic partnerships aimed at improving patient outcomes.